Abstract:Since the discovery of antibiotics, penicillin has remained the top choice in clinical medicine. With continuous advancements in biotechnology, penicillin production has become cost-effective and efficient. Genetic engineering techniques have been employed to enhance biosynthetic pathways, leading to the production of new penicillin derivatives with improved properties and increased efficacy against antibiotic-resistant pathogens. Advances in bioreactor design, media formulation, and process optimization have contributed to higher yields, reduced production costs, and increased penicillin accessibility. While biotechnological advances have clearly benefited the global production of this life-saving drug, they have also created challenges in terms of waste management. Production fermentation broths from industries contain residual antibiotics, by-products, and other contaminants that pose direct environmental threats, while increased global consumption intensifies the risk of antimicrobial resistance in both the environment and living organisms. The current geographical and spatial distribution of antibiotic and penicillin consumption dramatically reveals a worldwide threat. These challenges are being addressed through the development of novel waste management techniques. Efforts are aimed at both upstream and downstream processing of antibiotic and penicillin production to minimize costs and improve yield efficiency while lowering the overall environmental impact. Yield optimization using artificial intelligence (AI), along with biological and chemical treatment of waste, is also being explored to reduce adverse impacts. The implementation of strict regulatory frameworks and guidelines is also essential to ensure proper management and disposal of penicillin production waste. This review is novel because it explores the key remaining challenges in antibiotic development, the scope of machine learning tools such as Quantitative Structure-Activity Relationship (QSAR) in modern biotechnology-driven production, improved waste management for antibiotics, discovering alternative path to reducing antibiotic use in agriculture through alternative meat production, addressing current practices, and offering effective recommendations.

Harnessing biocatalysis as a green tool in antibiotic synthesis and discovery

Biocatalysis in drug discovery and development

Biocatalysis for Green Chemistry and Drug Development

Extending the application of biocatalysis to meet the challenges of drug development

Recent Advances in Biocatalysis for Drug Synthesis

Biocatalysis for the Synthesis of Pharmaceuticals and Pharmaceutical Intermediates

Biocatalysis for Drug Discovery and Development

Biocatalysis: landmark discoveries and applications in chemical synthesis

From nature to industry: Harnessing enzymes for biocatalysis

Catalyzing the future: recent advances in chemical synthesis using enzymes

State-of-the-Art Biocatalysis

Biocatalysis in Development of Green Pharmaceutical Processes.

Biocatalysis for the Synthesis of Active Pharmaceutical Ingredients in Deep Eutectic Solvents: State-of-the-Art and Prospects

Exploration of Chemical Biology Approaches to Facilitate the Discovery and Development of Novel Antibiotics

Strategies for designing biocatalysts with new functions

Combining chemistry and protein engineering for new-to-nature biocatalysis

Biocatalysis: Enzymatic Synthesis for Industrial Applications

Endophytic Fungi-Mediated Biocatalysis and Biotransformations Paving the Way Toward Green Chemistry

Application of Biocatalysis in the Synthesis of Enantiopure Drugs

Biocatalyst development by directed evolution.

Harnessing biotechnology for penicillin production: Opportunities and environmental considerations